Gonococcal antimicrobial susceptibility surveillance in Europe, 2016

surveillance report
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe
Cite:
Citation Link

European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2016. Stockholm: ECDC; 2018

Copy citation to clipboard

The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2016 gonococcal antimicrobial susceptibility sentinel surveillance.

Read more

Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Related updates on Neisseria gonorrhoeae

Publication

Gonorrhoea - Annual Epidemiological Report for 2017

surveillance report -

News

Gonorrhoea cases on the rise across Europe

news story -

News

Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe

ECDC comment -

Publication

Gonococcal antimicrobial susceptibility surveillance in Europe, 2017

surveillance report -

News

Gonorrhoea: drug resistance compromises recommended treatment in Europe

news story -